| Cancer Cytopathology | |
| Editor: | William C. Faquin |
| Discipline: | Pathology, Oncology |
| Publisher: | Wiley-Blackwell for the American Cancer Society |
| Country: | United States |
| Abbreviation: | Cancer Cytopathol. |
| Frequency: | Monthly |
| History: | 1997–present |
| Openaccess: | Hybrid |
| Impact: | 5.284 |
| Impact-Year: | 2020 |
| Website: | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1934-6638 |
| Link1: | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1934-6638/currentissue |
| Link1-Name: | Online access |
| Link2: | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1934-6638/issues |
| Link2-Name: | Online archive |
| Eissn: | 1934-6638 |
Cancer Cytopathology is a monthly peer-reviewed scientific journal which covers practice of cytopathology and its related oncology-based disciplines. It is one of three official journals of the American Cancer Society and is published by Wiley-Blackwell on behalf of the society. The current editor-in-chief is William C. Faquin. Cancer Cytopathology was published as a section of Cancer from 1997 until 2008 when it was split into a separate journal.[1]
The journal is abstracted and indexed in:According to the Journal Citation Reports, the journal has a 2020 impact factor of 5.284, ranking it 16th out of 77 journals in the category "Pathology" and 83rd out of 242 journals in "Oncology".[2]